Journal of the American Pharmaceutical Association最新文献_第8页

Trustworthiness and professional ethics. 诚信和职业道德。

Journal of the American Pharmaceutical Association Pub Date : 2002-07-01 DOI: 10.1331/108658002763029481

A. Haddad

引用次数: 1

Autoimmune rheumatic diseases in women. 女性自身免疫性风湿病

Journal of the American Pharmaceutical Association Pub Date : 2002-07-01 DOI: 10.1331/108658002763029599

A. Schuna

{"title":"Autoimmune rheumatic diseases in women.","authors":"A. Schuna","doi":"10.1331/108658002763029599","DOIUrl":"https://doi.org/10.1331/108658002763029599","url":null,"abstract":"OBJECTIVE\u0000To review the presenting symptoms, possible complications, treatment options, and reproductive considerations for rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, and Sjogren's syndrome.\u0000\u0000\u0000DATA SOURCES\u0000Articles retrieved from MEDLINE and OVID using the search terms women and female in combination with autoimmune disease, rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, and Sjogren's syndrome. References identified from citations in these articles were also reviewed.\u0000\u0000\u0000DATA SYNTHESIS\u0000Autoimmune rheumatic diseases are more common in women than in men and are most likely to manifest during the reproductive years. The reasons for this incidence pattern remain unclear but appear to be related to sex hormones and microchimerism. These diseases have varied clinical presentations that may be local or systemic and range from mild to severe. There is no cure for these autoimmune rheumatic diseases; treatments focus on managing symptoms. Many of the agents used for treating these diseases are contraindicated in pregnancy, posing special considerations for women who develop these diseases during their childbearing years.\u0000\u0000\u0000CONCLUSION\u0000Knowledge of the presenting symptoms of, treatment options for, and reproductive considerations with these diseases is important for pharmacists who counsel women with them.","PeriodicalId":17212,"journal":{"name":"Journal of the American Pharmaceutical Association","volume":"31 1","pages":"612-23; quiz 623-4"},"PeriodicalIF":0.0,"publicationDate":"2002-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89602862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 24

Medicaid managed care prescription use and cost savings. 医疗补助管理医疗处方使用和成本节约。

Journal of the American Pharmaceutical Association Pub Date : 2002-07-01 DOI: 10.1331/108658002763029562

T. Shireman, R. Hornung, M. Ho, C. Moomaw, R. Jang

{"title":"Medicaid managed care prescription use and cost savings.","authors":"T. Shireman, R. Hornung, M. Ho, C. Moomaw, R. Jang","doi":"10.1331/108658002763029562","DOIUrl":"https://doi.org/10.1331/108658002763029562","url":null,"abstract":"OBJECTIVE\u0000To evaluate the impact of Medicaid managed care (MC) enrollment on prescription use and costs.\u0000\u0000\u0000DESIGN\u0000Retrospective, cross-sectional analysis of claims submitted over a 6-month period.\u0000\u0000\u0000SETTING\u0000Ohio Medicaid.\u0000\u0000\u0000PATIENTS AND OTHER PARTICIPANTS\u0000Stratified, random selection of 2,932 MC and 1,335 fee-for-service (FFS) recipients.\u0000\u0000\u0000MAIN OUTCOME MEASURES\u0000Dependent variables were the probability of any prescription use and 6-month prescription counts and costs. Independent variables included age, plan enrollment (MC or FFS), county enrollment status (mandatory or voluntary), presence of a chronic comorbidity, and any outpatient medical visit.\u0000\u0000\u0000RESULTS\u0000After adjusting for comorbidities and outpatient medical visits, plan enrollment effects depended on age. FFS enrollees 8 to 12 and 12 to 18 years old were less likely (adjusted odds ratios 0.56 and 0.58, respectively) to receive a prescription, while enrollees over 30 years of age were 2.98 times more likely to receive a prescription. Among prescription users, level of use and costs were consistent across all ages for MC enrollees. FFS enrollees had 25% to 218% higher levels of prescription use than MC enrollees, depending on age. Prescription costs were 8% lower for FFS enrollees ages 4 to 8 but higher for all enrollees in other age groups (range, 22% to 311% higher).\u0000\u0000\u0000CONCLUSION\u0000Prescription use and costs were lower for Medicaid MC enrollees than they were for patients in traditional FFS plans. Further research is needed to examine the quality of care for both FFS and MC enrollees.","PeriodicalId":17212,"journal":{"name":"Journal of the American Pharmaceutical Association","volume":"77 1","pages":"587-93"},"PeriodicalIF":0.0,"publicationDate":"2002-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78079062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2

Time savings associated with dispensing unit-of-use packages. 节省与分配使用单元包装相关的时间。

Journal of the American Pharmaceutical Association Pub Date : 2002-07-01 DOI: 10.1331/108658002763029544

E. Lipowski, DeArcy E Campbell, D. Brushwood, Debbie L. Wilson

{"title":"Time savings associated with dispensing unit-of-use packages.","authors":"E. Lipowski, DeArcy E Campbell, D. Brushwood, Debbie L. Wilson","doi":"10.1331/108658002763029544","DOIUrl":"https://doi.org/10.1331/108658002763029544","url":null,"abstract":"OBJECTIVES\u0000To determine how much time can be saved with the use of unit-of-use packaging in a community pharmacy, the distribution of work between the pharmacist and the pharmacy technician when unit-of-use packaging is used, and the number of errors that occur when either unit-of-use or bulk packaging is used in dispensing prescriptions.\u0000\u0000\u0000DESIGN\u0000A simulation comparing count-and-pour dispensing with unit-of-use package dispensing.\u0000\u0000\u0000SETTING\u0000An independent community pharmacy.\u0000\u0000\u0000PARTICIPANTS\u0000Two teams, each composed of one pharmacist and one pharmacy technician.\u0000\u0000\u0000INTERVENTION\u0000Each team prepared 50 typical prescription orders, once using unit-of-use packaging and once by transferring medication from a bulk container.\u0000\u0000\u0000MAIN OUTCOME MEASURES\u0000Time needed to dispense 50 prescriptions, dispensing activities performed by technicians and pharmacists, and number of dispensing errors.\u0000\u0000\u0000RESULTS\u0000The time saved with unit-of-use packaging compared with count-and-pour dispensing was 46.5 minutes per 100 prescriptions, which represents an average time savings of more than 27 seconds per prescrition. In the bulk package dispensing simulation, the pharmacists assisted in retrieving and counting medication for 26% of the prescriptions. This percentage dropped to 4% when unit-of-use packaging was used because the technicians dispensed prescriptions at a rate that occupied the pharmacist with verifying the prescription orders and dispensed products. Each team committed two counting errors when executing the bulk package trial and no errors when using unit-of-use packaging.\u0000\u0000\u0000CONCLUSION\u0000Unit-of-use packaging can reduce the time needed for and increase the efficiency of pharmacists' dispensing activities. Unit-of-use packaging may also reduce the number of counting errors.","PeriodicalId":17212,"journal":{"name":"Journal of the American Pharmaceutical Association","volume":"6 1","pages":"577-81"},"PeriodicalIF":0.0,"publicationDate":"2002-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72863544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 11

American pharmaceutical education, 1952-2002. 美国药学教育，1952-2002。

Journal of the American Pharmaceutical Association Pub Date : 2002-07-01 DOI: 10.1331/108658002763029490

R. Buerki

引用次数: 3

Hyperlipidemia in Native Americans: evaluation of lipid management through a cardiovascular risk reduction program. 美洲原住民的高脂血症:通过心血管风险降低计划对脂质管理的评估。

Journal of the American Pharmaceutical Association Pub Date : 2002-07-01 DOI: 10.1331/108658002763029634

Randy Burden, Ritesh N. Kumar, D. Phillips, M. Borrego, J. Galloway

引用次数: 7

Accuracy of float testing for metered-dose inhaler canisters. 计量吸入器罐浮子试验的准确性。

Journal of the American Pharmaceutical Association Pub Date : 2002-07-01 DOI: 10.1331/108658002763029553

T. Brock, Andrea M. Wessell, Dennis Williams, J. Donohue

{"title":"Accuracy of float testing for metered-dose inhaler canisters.","authors":"T. Brock, Andrea M. Wessell, Dennis Williams, J. Donohue","doi":"10.1331/108658002763029553","DOIUrl":"https://doi.org/10.1331/108658002763029553","url":null,"abstract":"OBJECTIVE\u0000To characterize and evaluate canister floating patterns of three commercially available metered-dose inhalers (MDIs) with varying amounts of medication remaining.\u0000\u0000\u0000DESIGN\u0000Four canisters each of three asthma medications were studied. MDIs were actuated every 30 seconds to 60 seconds, and canisters were weighed and floated at 100%, 75%, 66%, 50%, 33%, 25%, 10%, and 0% of remaining labeled actuations. Position of the canisters and percentage submersion in water were recorded.\u0000\u0000\u0000SETTING\u0000Controlled laboratory.\u0000\u0000\u0000RESULTS\u0000We observed differences among the products with regard to canister floating behavior at varying levels of fullness. All canisters were completely submerged with the nozzle up at two-thirds full and greater. The canisters remained nozzle-up and were submerged to varying levels at the half-full point. When observed at less than half full, canisters inverted and floated nozzle down. Positions of the canisters varied among products at less than half full. No canister was fully tilted when all labeled actuations were used.\u0000\u0000\u0000CONCLUSION\u0000Float characteristics are product-specific and a function of canister size, design, content, and method of testing. Clinicians and asthma educators should not advise patients to use a float test to assess the amount of medication remaining in an MDI. Recommendations from the National Asthma Education and Prevention Program of the National Heart, Lung, and Blood Institute suggest that the only reliable method for determining the number of doses remaining in a canister is to subtract the number of doses used from the number available.","PeriodicalId":17212,"journal":{"name":"Journal of the American Pharmaceutical Association","volume":"21 1","pages":"582-6"},"PeriodicalIF":0.0,"publicationDate":"2002-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88306000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 17

Observations of pharmacy practice in the Dmitrov Raion, Russia. 俄罗斯德米特罗夫地区药学实践观察。

Journal of the American Pharmaceutical Association Pub Date : 2002-07-01 DOI: 10.1331/108658002763029508

M. Indritz

引用次数: 4

Safe" considerations: burglary- and fire-resistant devices for the pharmacy. 安全考虑:药房的防盗和防火装置。

Journal of the American Pharmaceutical Association Pub Date : 2002-07-01 DOI: 10.1331/108658002763029517

Virgil Van Dusen

引用次数: 1

APhA's Proposed Name Change and House of Delegates 2002 2002年，APhA提议更名和众议院

Journal of the American Pharmaceutical Association Pub Date : 2002-07-01 DOI: 10.1331/108658002763029472

A. Kibbe, V. Prince, Heather R. Ferguson

引用次数: 0